Given that these studies focused on the existence of low levels of PTENP1 in cancer and its activity as a tumor suppressor, we expect it to be a promising candidate biomarker for the early detection of cancer in the future, as its reduced expression may predict poor prognosis for various tumors [34]. This evidence concerns the gene PTENP1 and cancer.